Warren Buffett discussed rational business valuation while Amgen's TSR exceeded its share price return.
1 report, 1 independent
Updated Jul 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Warren Buffett discussed rational business valuation while Amgen's TSR exceeded its share price return.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
Nothing else this week.
-
Warren Buffett
American investor, entrepreneur and businessman
Nothing else this week.
-
TSR
former company, publisher of Dungeons & Dragons
Nothing else this week.
Related events
- Warren Buffett's investment approach is cited in relation to Mirae Asset.
- Warren Buffett is described as the guiding figure behind the Berkshire Hathaway conglomerate.
- Warren Buffett's philosophy on company durability is applied to Microsoft and Amazon, noting their resilience during the dot-com bear market.
- Warren Buffett's investment advice is related to market behavior studies conducted by Dimensional Fund Advisors.
Coverage
Newest first; wire copies grouped- Simply Wall St.Amgen's (NASDAQ:AMGN) three-year earnings growth trails the 10% YoY shareholder returns Buying a low-cost index fund will get you the average market return. But across the board there are plenty of s